ABC00088IS

Olanzapine EP impurity B

Olanzapine EP Impurity B is a structurally related degradation product derived from the oxidative cleavage of the piperidine ring in the parent antipsychotic compound. It retains the thieno[2,3-b]pyridine core and 2-chlorophenyl substitution but features a truncated piperazine moiety replaced by a 4-methylpiperazin-1-yl group linked via a pyridine bridge. This impurity exhibits reduced aromatic substitution at the terminal phenyl ring compared to Olanzapine, resulting in altered lipophilicity and chromatographic behavior. It functions as a reference standard for HPLC-based quantification of oxidative degradation pathways in Olanzapine drug substances.

On Request
Molecular Formula C24H20N4O2S2
Molecular Weight 460.6000
CAS Number N/A
Purity 95%
Product Type API Impurity
Parent Drug Olanzapine
Lead Time 14 Days
IUPAC Name 2-Methyl-5,10-dihydro-4H-thieno[2,3-b][1,5]benzodiazepin-4-one (as per EP); 2-Methyl-10H-thieno-[2,3-b][1,5]benzodiazepin-4[5H]-one

๐Ÿ“ Synonyms

Olanzapine EP Impurity B

๐Ÿ”ฌ Chemical Identifiers

CC1=CC2=C(S1)NC3=CC=CC=C3NC2=O.CC1=CC2=C(S1)NC3=CC=CC=C3NC2=O
InChI=1S/2C12H10N2OS/c2*1-7-6-8-11(15)13-9-4-2-3-5-10(9)14-12(8)16-7/h2*2-6,14H,1H3,(H,13,15)
BQBHNLACBOOLSF-UHFFFAOYSA-N

Related Products